Kimia Biosciences Limited (BOM:530313)
India flag India · Delayed Price · Currency is INR
30.15
-0.11 (-0.36%)
At close: Mar 9, 2026

Kimia Biosciences Company Description

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India.

The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals.

It exports its products. Kimia Biosciences Limited was formerly known as Laurel Organics Ltd and changed its name to Kimia Biosciences Limited January 2019.

The company was incorporated in 1993 and is based in New Delhi, India.

Kimia Biosciences Limited
Country India
Founded 1993
Industry Medicinal Chemicals and Botanical Products
Employees 250
CEO Sameer Goel

Contact Details

Address:
974, Aggarwal Millennium Tower II
New Delhi, Haryana 110034
India
Phone 91 11 4706 3600
Website kimiabiosciences.com

Stock Details

Ticker Symbol 530313
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2833

Key Executives

Name Position
Sameer Goel Chief Executive Officer
Kaku Vijaya Reddy Chief Operating Officer